IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 2 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $293,000 | -59.9% | 51,550 | -80.4% | 0.17% | +152.2% |
| Q3 2018 | $730,000 | +25.9% | 262,750 | 0.0% | 0.07% | +24.1% |
| Q2 2018 | $580,000 | +504.2% | 262,750 | +381.7% | 0.05% | +12.5% |
| Q1 2018 | $96,000 | -5.9% | 54,550 | -8.9% | 0.05% | -2.0% |
| Q4 2017 | $102,000 | +4.1% | 59,900 | -1.3% | 0.05% | +6.5% |
| Q3 2017 | $98,000 | -50.0% | 60,700 | -0.7% | 0.05% | -48.3% |
| Q2 2017 | $196,000 | -84.6% | 61,100 | -80.0% | 0.09% | -24.6% |
| Q1 2017 | $1,275,000 | +691.9% | 305,500 | +373.6% | 0.12% | +57.3% |
| Q4 2016 | $161,000 | -35.6% | 64,500 | -1.5% | 0.08% | -38.5% |
| Q3 2016 | $250,000 | +1.6% | 65,500 | 0.0% | 0.12% | -6.2% |
| Q2 2016 | $246,000 | -5.4% | 65,500 | 0.0% | 0.13% | -13.3% |
| Q1 2016 | $260,000 | -54.5% | 65,500 | -14.0% | 0.15% | -43.8% |
| Q4 2014 | $571,000 | -30.6% | 76,128 | -31.3% | 0.27% | -30.6% |
| Q3 2014 | $823,000 | +6.7% | 110,853 | -0.2% | 0.38% | +26.2% |
| Q2 2014 | $771,000 | +3.5% | 111,053 | 0.0% | 0.30% | -3.2% |
| Q1 2014 | $745,000 | +82.6% | 111,053 | 0.0% | 0.32% | +85.3% |
| Q4 2013 | $408,000 | +41.7% | 111,053 | +73.2% | 0.17% | +33.9% |
| Q3 2013 | $288,000 | -47.1% | 64,100 | 0.0% | 0.13% | -50.0% |
| Q2 2013 | $544,000 | – | 64,100 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|